Marquart M E, Picking W L, Picking W D
Department of Biology, Saint Louis University, Missouri 63103-2010, USA.
Infect Immun. 1996 Oct;64(10):4182-7. doi: 10.1128/iai.64.10.4182-4187.1996.
Shigella flexneri invades colonic epithelial cells by pathogen-induced phagocytosis. The three proposed effectors of S. flexneri internalization are invasion plasmid antigens B (IpaB), IpaC, and IpaD, which are encoded on the pathogen's 230-kb virulence plasmid and translocated to the extracellular milieu via the Mxi-Spa translocon. To date, there are no definitive functional data for any purified Ipa protein. Here, we describe the first characterization of highly purified recombinant IpaC, which elicits numerous epithelial cell responses related to events that take place during pathogen invasion. 125I-labeled IpaC binds cultured Henle 407 intestinal cells with an apparent dissociation constant in the low micromolar range. Moreover, incubation of epithelial cells with IpaC results in general changes in cellular phosphoprotein content, demonstrating this protein's ability to influence cellular protein kinase activities. These results contrast dramatically with those seen for recombinant IpaD, which does not bind to or induce detectable changes in the normal activities of cultured epithelial cells. In addition to influencing host cell activities, preincubation of epithelial cells with purified IpaC enhances uptake of S. flexneri by host cells. A similar result is seen when the cells are preincubated with a highly concentrated water extract of virulent S. flexneri 2a (strain 2457T). Interestingly, soluble IpaC also appears to promote uptake of the noninvasive S. flexneri 2a strain BS103. Purified IpaD failed to enhance the uptake of virulent S. flexneri and did not facilitate uptake of BS103. Taken together, the data suggest that IpaC is a potential effector of the host cell biological activities and may be responsible for entry of S. flexneri into target cells.
福氏志贺菌通过病原体诱导的吞噬作用侵入结肠上皮细胞。关于福氏志贺菌内化作用的三种假定效应蛋白是侵袭质粒抗原B(IpaB)、IpaC和IpaD,它们由病原体的230 kb毒力质粒编码,并通过Mxi-Spa转运体转运到细胞外环境中。迄今为止,对于任何纯化的Ipa蛋白都没有确切的功能数据。在此,我们描述了高度纯化的重组IpaC的首次特性分析,它引发了许多与病原体入侵过程中发生的事件相关的上皮细胞反应。125I标记的IpaC以低微摩尔范围的表观解离常数与培养的Henle 407肠细胞结合。此外,用IpaC孵育上皮细胞会导致细胞磷蛋白含量发生总体变化,表明该蛋白能够影响细胞蛋白激酶活性。这些结果与重组IpaD的结果形成了显著对比,重组IpaD不与培养的上皮细胞结合,也不会诱导其正常活性发生可检测到的变化。除了影响宿主细胞活性外,用纯化的IpaC预孵育上皮细胞还能增强宿主细胞对福氏志贺菌的摄取。当细胞与强毒株福氏志贺菌2a(菌株2457T)的高浓缩水提取物预孵育时,也会出现类似结果。有趣的是,可溶性IpaC似乎还能促进非侵袭性福氏志贺菌2a菌株BS103的摄取。纯化的IpaD未能增强强毒株福氏志贺菌的摄取,也不能促进BS103的摄取。综上所述,这些数据表明IpaC是宿主细胞生物学活性的潜在效应蛋白,可能负责福氏志贺菌进入靶细胞。